Last reviewed · How we verify
quadrivalent influenza split vaccine — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
quadrivalent influenza split vaccine (quadrivalent influenza split vaccine) — Jiangsu Province Centers for Disease Control and Prevention.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| quadrivalent influenza split vaccine TARGET | quadrivalent influenza split vaccine | Jiangsu Province Centers for Disease Control and Prevention | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- quadrivalent influenza split vaccine CI watch — RSS
- quadrivalent influenza split vaccine CI watch — Atom
- quadrivalent influenza split vaccine CI watch — JSON
- quadrivalent influenza split vaccine alone — RSS
Cite this brief
Drug Landscape (2026). quadrivalent influenza split vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/quadrivalent-influenza-split-vaccine. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab